New Drugs
| Brand/Generic | Company | Description |
|---|---|---|
|
Brenzavvy bexagliflozin Click here for more information |
TheracosBio | A new sodium-glucose co-transporter 2 (SGLT2) inhibitor for the treatment of type 2 diabetes. |
|
Daybue trofinetide Click here for more information |
Acadia Pharm | A new medication for the treatment of Rett syndrome (unknown mechanism). |
|
Filspari sparsentan Click here for more information |
Travere Therapeutics | A new endothelin and angiotensin II receptor antagonist to reduce proteinuria in adults. |
|
Jaypirca pirtobrutinib Click here for more information |
Eli Lilly | A new kinase inhibitor for the treatment of mantle cell lymphoma (MCL). |
|
Jesduvroq daprodustat Click here for more information |
GlaxoSmithKline | A new oral hypoxia-inducible factor prolyl hydroxylase (HIF PH) inhibitor for the treatment of anemia in patients with chronic kidney disease receiving dialysis. |
|
Lamzede velmanase alfa-tycv Click here for more information |
Chiesi USA | A new recombinant human lysosomal alpha-mannosidase for the treatment of non-central nervous system manifestations of alpha-mannosidiosis. |
|
Leqembi lecanemab-irmb Click here for more information |
Eisai | A new amyloid beta-directed antibody for the treatment of Alzheimer’s disease. |
|
Orserdu elacestrant Click here for more information |
Stemline Therapeutics | A new estrogen receptor antagonist for the treatment of breast cancer. |
|
Skyclarys omaveloxolone Click here for more information |
Reata Pharmaceuticals | A new treatment of Friedreich’s ataxia (unknown mechanism). |
|
Zavzpret zavegepant Click here for more information |
Pfizer | A new calcitonin gene-related peptide (CGRP) receptor antagonist for treatment of acute migraine in adults. |
| Brand/Generic | Company | Description |
|---|---|---|
|
Airsupra albuterol/budesonide Click here for more information |
AstraZeneca | A new combination metered-dose inhaler for the treatment of asthma. |
|
Atorvaliq atorvastatin Click here for more information |
CMP Pharma | A new oral suspension to lower cholesterol. |
|
Combogesic acetaminophen/ ibuprofen Click here for more information |
AFT Pharm | A new combination product for the treatment of mild to moderate acute pain. |
|
Prevduo neostigmine/glycopyrrolate Click here for more information |
Slayback Pharma | A new fixed-dose combination to reverse the effects of non-depolarizing neuromuscular blocking agents after surgery. |
|
Rykindo risperidone Click here for more information |
Shandong Luye Pharm | A new long-acting injectable for schizophrenia and bipolar disorder. |
|
Syfovre pegcetacoplan Click here for more information |
Apellis Pharm | A new injection for intravitreal use to treat geographic atrophy secondary to age-related macular degeneration. |
| Brand/Generic | Company | Description |
|---|